1
|
Kerleroux B, Hak JF, Lapergue B, Bricout N, Zhu F, Inoue M, Janot K, Dargazanli C, Kaesmacher J, Rouchaud A, Forestier G, Gortais H, Benzakoun J, Yoshimoto T, Consoli A, Ben Hassen W, Henon H, Naggara O, Boulouis G. Endovascular therapy in patients with a large ischemic volume at presentation: An aggregate patient-level analysis. Clin Neurol Neurosurg 2024; 244:108452. [PMID: 39059286 DOI: 10.1016/j.clineuro.2024.108452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2024] [Revised: 07/03/2024] [Accepted: 07/12/2024] [Indexed: 07/28/2024]
Abstract
INTRODUCTION Recently, four randomized controlled trials (RCTs) have demonstrated the benefits of mechanical thrombectomy (MT) in patients with acute ischemic stroke (AIS) caused by anterior large vessel occlusion (LVO) and a large ischemic core at baseline (LIC). The purpose of this study was to investigate the features influencing the clinical outcome and the benefits of mechanical thrombectomy in this subgroup. METHODS We conducted a multicenter retrospective aggregate cohort study of patients with AIS-LVO and a LIC, assessed with quantitative core volume measures, treated with MT between 2012 and 2019. The data were queried through four registries, including patients with core volumes ≥50cc. Multivariable logistic regression models were employed to determine factors independently associated with clinical outcomes in patients with successful recanalization (modified-Thrombolysis-in-Cerebral-Infarction-score, mTICI=2b-3) and unsuccessful recanalization group (mTICI=0-2a). The primary endpoint was a favorable functional outcome at day-90, defined as a modified Rankin scale (mRS) of 0-3, accounting for the inherent severity of AIS with baseline LIC. Secondary outcomes included functional independence (mRS 0-2) at day-90, mortality, and symptomatic Intracranial Hemorrhage (sICH). RESULTS A total of 460 patients were included (mean age 66±14.2 years; 39.6 % females). The mean baseline NIHSS was 20±5.2, and the core volume was 103.2±54.6 ml. Overall, 39.8 % (183/460) of patients achieved a favorable outcome at day-90 (mRS 0-3). Successful recanalization was significantly associated with a more frequent favorable outcome (aOR, 4.79; 95 %CI, 2.73-8.38; P<0.01) and functional independence (P<0.01). This benefit remained significant in older patients and in patients with cores above 100cc. At 90 days, 147/460 patients (32 %) were deceased, with successful recanalization significantly associated with less frequent mortality (OR, 0.34; 95 %CI, 0.22-0.53; P<0.01). The rate of sICH was 17.4 % and did not differ significantly between groups. CONCLUSIONS In this large, pooled-cohort study of AIS-LVO patients with infarct cores over 50cc at baseline, we demonstrated that successful recanalization was associated with a better functional outcome, lower mortality, and similar rates of symptomatic intracranial hemorrhage for a wide spectrum of patients.
Collapse
Affiliation(s)
- Basile Kerleroux
- Department of Neuroradiology, CHU Marseille La Timone, Marseille, France.
| | - Jean François Hak
- Department of Neuroradiology, CHU Marseille La Timone, Marseille, France
| | | | - Nicolas Bricout
- Diagnostic and Interventional Neuroradiology, CHRU Lille, Lille, France
| | - François Zhu
- University Hospital of Nancy, Department of Diagnostic and Therapeutic Neuroradiology, INSERM U1254, IADI, Nancy F-54000, France
| | - Manabu Inoue
- Department of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita Japan
| | - Kevin Janot
- Department of Neuroradiology, CHRU Tours, Tours, France
| | - Cyril Dargazanli
- Neuroradiology Department, CHRU Gui de Chauliac, Montpellier, France
| | - Johannes Kaesmacher
- Institute of Diagnostic, Interventional and Pediatric Radiology and Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland
| | - Aymeric Rouchaud
- Neuroradiology department, Dupuytren, University Hospital of Limoges, France
| | - Géraud Forestier
- Neuroradiology department, Dupuytren, University Hospital of Limoges, France
| | - Hugo Gortais
- Department of Neuroradiology, GHU Paris Psychiatrie et Neurosciences, Hospitalier Sainte Anne, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Université de Paris Centre, France
| | - Joseph Benzakoun
- Department of Neuroradiology, GHU Paris Psychiatrie et Neurosciences, Hospitalier Sainte Anne, Institut de Psychiatrie et Neurosciences de Paris (IPNP), UMR_S1266, INSERM, Université de Paris Centre, France
| | - Takeshi Yoshimoto
- Department of Neurology, National Cerebral and Cardiovascular Center Suita, Japan
| | - Arturo Consoli
- Department of Diagnostic and Interventional Neuroradiology, Foch Hospital, Suresnes, France
| | - Wagih Ben Hassen
- Department of Neuroradiology, CHU Marseille La Timone, Marseille, France
| | - Hilde Henon
- Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, Lille F-59000, France
| | - Olivier Naggara
- Department of Neuroradiology, CHU Marseille La Timone, Marseille, France
| | | |
Collapse
|
2
|
Ifergan H, Dargazanli C, Ben Hassen W, Hak JF, Gory B, Ognard J, Premat K, Marnat G, Kerleroux B, Zhu F, Bellanger G, Sporns PB, Charbonnier G, Forestier G, Caroff J, Fauché C, Clarençon F, Janot K, Lapergue B, Boulouis G. Rescue intracranial permanent stenting for refractory occlusion following thrombectomy: a propensity matched analysis. J Neurointerv Surg 2024; 16:115-123. [PMID: 37080770 DOI: 10.1136/jnis-2022-020012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2022] [Accepted: 03/25/2023] [Indexed: 04/22/2023]
Abstract
BACKGROUND Rescue intracranial stenting (RIS) can be used in refractory large vessel occlusion (LVO) after mechanical thrombectomy (MT). We aimed to assess the safety and efficacy of RIS versus a propensity matched sample of patients with persistent LVO. METHODS We retrospectively analysed a multicenter retrospective pooled cohort of patients with anterior LVO (2015-2021) treated with MT, and identified patients with at least three passes and a modified Thrombolysis In Cerebral Infarction (mTICI) score of 0 to 2a. Propensity score matching was used to account for determinants of outcome in patients with or without RIS. The study outcomes included 3 months modified Rankin Scale (mRS) and symptomatic hemorrhagic transformation (HT). RESULTS 420 patients with a refractory anterior occlusion were included, of which 101 were treated with RIS (mean age 69 years). Favorable outcome (mRS 0-2) was more frequent in patients with a patent stent at day 1 (53% vs 6%, P<0.001), which was independently associated with an early dual antiplatelet regimen (P<0.05). In the propensity matched sample, patients treated with RIS versus without RIS had similar rates of favorable outcomes (36.8% vs 30.3%, P=0.606). Patients with RIS showed a favorable shift in the overall mRS distributions (common adjusted OR 0.74, 95% CI 0.60 to 0.91, P=0.006). Symptomatic HT was marginally more frequent in the RIS group (9% vs 3%, P=0.07), and there was no difference in 3-month mortality. CONCLUSION In selected patients with a refractory intracranial occlusion despite at least three thrombectomy passes, RIS may be associated with an overall shift towards more favorable clinical outcome, and no significant increase in the odds of symptomatic HT or death.
Collapse
Affiliation(s)
- Heloise Ifergan
- Diagnostic and Interventional Neuroradiology, University Hospital of Tours, Tours, Centre, France
| | - Cyril Dargazanli
- Diagnostic and Interventional Neuroradiology, University Hospital Centre Montpellier, Montpellier, Occitanie, France
| | - Wagih Ben Hassen
- Diagnostic and Interventional Neuroradiology, Saint Anne Hospital Centre, Paris, France
| | - Jean-Francois Hak
- Diagnostic and Interventional Neuroradiology, Hospital Timone, University Hospital of Marseille, Marseille, France
| | - Benjamin Gory
- Department of Diagnostic and Therapeutic Neuroradiology, University of Lorraine, INSERM U1254, IADI, F-54000, University Hospital of Nancy, Nancy, France
| | - Julien Ognard
- Diagnostic and Interventional Neuroradiology, University and Regional Hospital Centre Brest, Brest, France
| | - Kevin Premat
- Diagnostic and Interventional Neuroradiology, University Hospital of Pitié Salpêtrière, APHP, Paris, France
| | - Gaultier Marnat
- Diagnostic and Interventional Neuroradiology, University Hospital of Bordeaux, Bordeaux, France
| | - Basile Kerleroux
- Diagnostic and Interventional Neuroradiology, Saint Anne Hospital Centre, Paris, France
| | - François Zhu
- Diagnostic and Interventional Neuroradiology, University Hospital of Nancy, Nancy, France
| | - Guillaume Bellanger
- Diagnostic and Interventional Neuroradiology, University Hospital of Toulouse, Toulouse, France
| | - Peter B Sporns
- Diagnostic and Interventional Neuroradiology, University Hospital of Basel, Basel, Switzerland
| | - Guillaume Charbonnier
- Diagnostic and Interventional Neuroradiology, University Hospital of Besançon, Besancon, France
| | - Géraud Forestier
- Diagnostic and Interventional Neuroradiology, University Hospital of Limoges, Limoges, France
| | - Jildaz Caroff
- Department of Interventional Neuroradiology - NEURI Brain Vascular Center, Bicêtre Hospital, APHP, Le Kremlin Bicêtre, France
| | - Cédric Fauché
- Diagnostic and Interventional Neuroradiology, University Hospital of Poitiers, Poitiers, France
| | - Frédéric Clarençon
- Diagnostic and Interventional Neuroradiology, University Hospital of Pitié Salpêtrière, APHP, Paris, France
| | - Kevin Janot
- Diagnostic and Interventional Neuroradiology, University Hospital of Tours, Tours, Centre, France
| | - Bertrand Lapergue
- Neurology, Stroke Center, University of Versailles and Saint Quentin en Yvelines, Foch Hospital, Suresnes, France
| | - Gregoire Boulouis
- Diagnostic and Interventional Neuroradiology, University Hospital of Tours, Tours, Centre, France
| |
Collapse
|
3
|
Lognon P, Gariel F, Marnat G, Darcourt J, Constant Dit Beaufils P, Burel J, Shotar E, Hak JF, Fauché C, Kerleroux B, Guédon A, Ognard J, Forestier G, Pop R, Paya C, Veyrières JB, Sporns P, Girot JB, Zannoni R, Zhu F, Crespy A, L'Allinec V, Mihoc D, Rouchaud A, Gentric JC, Ben Hassen W, Raynaud N, Testud B, Clarençon F, Kaczmarek B, Bourcier R, Bellanger G, Boulouis G, Janot K. Prospective assessment of aneurysmal rupture risk scores in patients with subarachnoid hemorrhage: a multicentric cohort. Neuroradiology 2022; 64:2363-2371. [PMID: 35695927 DOI: 10.1007/s00234-022-02987-w] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2022] [Accepted: 05/20/2022] [Indexed: 12/21/2022]
Abstract
PURPOSE The natural evolution of unruptured intracranial aneurysms (UIA) is indeed difficult to predict at the individual level. OBJECTIVE In a large prospective multicentric European cohort, we aimed to evaluate whether the PHASES, UCAS, and ELPASS scores in patients with aneurysmal subarachnoid hemorrhage would have predicted a high risk of aneurysmal rupture or growth. METHODS Academic centers treating patients with intracranial aneurysms were invited to prospectively collect de-identified data from all patients admitted at their institution for a subarachnoid hemorrhage-related to intracranial aneurysmal rupture between January 1 and March 31, 2021 through a trainee-led research collaborative network. Each responding center was provided with an electronic case record form (CRF) which collected all the elements of the PHASES, ELAPSS, and UCAS scores. RESULTS A total of 319 patients with aneurysmal subarachnoid hemorrhage were included at 17 centers during a 3-month period. One hundred eighty-three aneurysms (57%) were less than 7 mm. The majority of aneurysms were located on the anterior communicating artery (n = 131, 41%). One hundred eighty-four patients (57%), 103 patients (32%), and 58 (18%) were classified as having a low risk of rupture or growth, according to the PHASES, UCAS, and ELAPSS scores, respectively. CONCLUSION In a prospective study of European patients with aneurysmal subarachnoid hemorrhage, we showed that 3 common risk-assessment tools designed for patients with unruptured intracranial aneurysms would have not identified most patients to be at high or intermediate risk for rupture, questioning their use for decision-making in the setting of unruptured aneurysms.
Collapse
Affiliation(s)
- P Lognon
- University Hospital of Tours, Tours, France
| | - F Gariel
- University Hospital of Bordeaux, Bordeaux, France
| | - G Marnat
- University Hospital of Bordeaux, Bordeaux, France
| | - J Darcourt
- University Hospital of Toulouse, Toulouse, France
| | - P Constant Dit Beaufils
- L'institut du Thorax, University of Nantes, INSERM, CNRS, Nantes, France.,University Hospital of Nantes, Nantes, France
| | - J Burel
- University Hospital of Rouen, Rouen, France
| | - E Shotar
- Pitié Salpêtrière Hospital, Paris, France
| | - J F Hak
- University Hospital of Marseille, Marseille, France
| | - C Fauché
- University Hospital of Poitiers, Poitiers, France
| | | | - A Guédon
- Lariboisière Hospital, Paris, France
| | - J Ognard
- University Hospital of Brest, Brest, France
| | - G Forestier
- University Hospital of Limoges, Limoges, France
| | - R Pop
- University Hospital of Strasbourg, Strasbourg, France
| | - C Paya
- University Hospital of Saint-Pierre, Saint-Pierre, La Réunion, France
| | - J B Veyrières
- University Hospital of Saint-Pierre, Saint-Pierre, La Réunion, France
| | - P Sporns
- University Hospital of Basel, Basel, Switzerland.,University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
| | - J B Girot
- University Hospital of Angers, Angers, France
| | - R Zannoni
- University Hospital of Saint-Etienne, Saint-Etienne, France
| | - F Zhu
- University Hospital of Nancy, Nancy, France
| | - A Crespy
- University Hospital of Tours, Tours, France
| | - V L'Allinec
- University Hospital of Angers, Angers, France
| | - D Mihoc
- University Hospital of Strasbourg, Strasbourg, France
| | - A Rouchaud
- University Hospital of Limoges, Limoges, France
| | | | | | - N Raynaud
- University Hospital of Poitiers, Poitiers, France
| | - B Testud
- University Hospital of Marseille, Marseille, France
| | | | | | - R Bourcier
- L'institut du Thorax, University of Nantes, INSERM, CNRS, Nantes, France.,University Hospital of Nantes, Nantes, France
| | - G Bellanger
- University Hospital of Toulouse, Toulouse, France
| | - G Boulouis
- University Hospital of Tours, Tours, France
| | - Kevin Janot
- University Hospital of Tours, Tours, France.
| | | |
Collapse
|
4
|
Forestier G, Escalard S, Sedat J, Saleme S, Mounayer C, Montcuquet A, Smajda S, Cantier M, Gregoire C, Hankiewicz K, Chau Y, Suissa L, Berge J, Clarençon F, Rouchaud A, Shotar E. Non-ischemic cerebral enhancing lesions after thrombectomy: a multicentric retrospective French national registry. Neuroradiology 2022; 64:1037-1042. [PMID: 35199209 DOI: 10.1007/s00234-022-02919-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Accepted: 02/17/2022] [Indexed: 10/19/2022]
Abstract
To report the occurrence of non-ischemic cerebral enhancing (NICE) lesions following mechanical thrombectomy (MT) through the retrospective French nationwide registry of NICE lesions. All thrombectomy capable stroke centers (TSC) in France were invited to fill out a questionnaire disseminated through a trainee-led research network (JENI-RC: Jeunes en Neuroradiologie Interventionnelle-Research Collaborative). NICE lesions were defined according to previous literature as delayed onset punctate, nodular, or annular foci enhancements with peri-lesion edema and vascular distribution in the territory of the MT with no other confounding disease. All 43 TSC French centers responded. Three patients were reported by 3 different centers over a total of 34,824 MT (2015-2020). Patient no. 1 developed symptomatic NICE lesions 8 weeks after MT with combination of aspiration and stentriever for a right middle cerebral artery occlusion. Patient no. 2 developed asymptomatic NICE lesions 5 weeks after MT with direct thromboaspiration for a right middle cerebral artery occlusion. Patient no. 3 developed symptomatic NICE lesions 6 weeks after MT with direct thromboaspiration, and combination of aspiration and stentriever for a basilar artery occlusion. This study provides evidence that NICE lesions following MT are a possible rare complication with a similar presentation as previously described following endovascular aneurysm treatment. Both radiologists and neurologists should be aware of this adverse event and make use of MRI contrast agents in case of unexplained symptoms/images during follow-up after MT.
Collapse
Affiliation(s)
- Géraud Forestier
- Neuroradiology Department, University Hospital of Limoges, CHU LIMOGES, 2 avenue Martin Luther-King, 87000, Limoges, France.
| | - Simon Escalard
- Interventional Neuroradiology Department, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - Jacques Sedat
- Interventional Neuroradiology Department, Nice University Hospital, Nice, France
| | - Suzana Saleme
- Neuroradiology Department, University Hospital of Limoges, CHU LIMOGES, 2 avenue Martin Luther-King, 87000, Limoges, France
| | - Charbel Mounayer
- Neuroradiology Department, University Hospital of Limoges, CHU LIMOGES, 2 avenue Martin Luther-King, 87000, Limoges, France.,XLIM CNRS, UMR7252, Université de Limoges, Limoges, France
| | - Alexis Montcuquet
- Neurology Department, University Hospital of Limoges, Limoges, France
| | - Stanislas Smajda
- Interventional Neuroradiology Department, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - Marie Cantier
- Neuro-Intensive Care Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - Charles Gregoire
- Neuro-Intensive Care Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
| | - Karolina Hankiewicz
- Neurology Department, Centre Hospitalier de Saint Denis, Hôpital Delafontaine, Saint-Denis, France
| | - Yves Chau
- Interventional Neuroradiology Department, Nice University Hospital, Nice, France
| | - Laurent Suissa
- Unité Neurovasculaire, Hôpital La Timone, CHU de Marseille, Marseille, France
| | - Jérôme Berge
- Neuroradiology Department, University Hospital of Bordeaux, Bordeaux, France
| | | | - Aymeric Rouchaud
- Neuroradiology Department, University Hospital of Limoges, CHU LIMOGES, 2 avenue Martin Luther-King, 87000, Limoges, France.,XLIM CNRS, UMR7252, Université de Limoges, Limoges, France
| | - Eimad Shotar
- Department of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France
| | | |
Collapse
|